drugset / Trial / NCT00240695
A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive Impairment
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this follow-up study is to assess the long-term safety and tolerability of galantamine in individuals with mild cognitive impairment who participated in a previous study with galantamine
Timeline
- Start
- 2003-05
- Primary completion
- —
- Completion
- 2004-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Galantamine | Small molecule | 8 mg | Oral |
| Subject | Galantamine | Small molecule | 12 mg | Oral |